Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
Choi et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2020.10.062
https://c19hcq.org/choi.html